Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2018-01-17 21:23:57
Reporting Period:
Accepted Time:
2018-01-17 21:23:57
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1629383 Sarah Boyce C/o Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-15 5,367 $0.00 11,127 No 4 M Direct
Common Stock Disposition 2018-01-16 2,196 $51.76 8,931 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2018-01-15 12,916 $0.00 12,916 $0.00
Common Stock Restricted Stock Units Disposition 2018-01-15 5,367 $0.00 5,367 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,916 No 4 A Direct
10,427 No 4 M Direct
  1. Acquired pursuant to vesting and release of shares pursuant to Restricted Stock Unit awards.
  2. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
  3. Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan.
  4. Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
  5. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.